(0.10%) 5 522.25 points
(0.12%) 39 892 points
(0.23%) 19 796 points
(0.01%) $81.64
(0.46%) $2.82
(-0.32%) $2 336.80
(-0.02%) $29.52
(0.21%) $1 003.90
(0.01%) $0.931
(-0.01%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
0.02% $ 45.23
Live Chart Being Loaded With Signals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology...
Stats | |
---|---|
Dzisiejszy wolumen | 465 719 |
Średni wolumen | 806 961 |
Kapitalizacja rynkowa | 2.57B |
EPS | $-1.450 ( Q1 | 2024-05-02 ) |
Następna data zysków | ( $-1.570 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-7.17 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0490 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Fouse Jacqualyn A | Buy | 11 774 | Stock options (right to buy) |
2024-06-20 | Fouse Jacqualyn A | Buy | 2 120 | Restricted stock units |
2024-06-20 | Smith Cynthia | Buy | 11 774 | Stock options (right to buy) |
2024-06-20 | Smith Cynthia | Buy | 2 120 | Restricted stock units |
2024-06-20 | Capello Jeffrey D | Buy | 11 774 | Stock options (right to buy) |
INSIDER POWER |
---|
38.00 |
Last 100 transactions |
Buy: 929 786 | Sell: 420 745 |
Wolumen Korelacja
Agios Pharmaceuticals Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
OZEM | 1 |
ORGN | 0.94 |
MAMA | 0.928 |
DFLI | 0.928 |
MSAQX | 0.92 |
EVCGX | 0.917 |
AAIDX | 0.916 |
MACK | 0.91 |
TXRH | 0.908 |
PMGM | 0.907 |
10 Najbardziej negatywne korelacje | |
---|---|
FORR | -0.918 |
VREX | -0.917 |
RFAIU | -0.917 |
CLMB | -0.916 |
QDEL | -0.914 |
GPRO | -0.913 |
REKR | -0.911 |
CCRN | -0.911 |
FUFUW | -0.909 |
CYAN | -0.905 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Agios Pharmaceuticals Inc Korelacja - Waluta/Towar
Agios Pharmaceuticals Inc Finanse
Annual | 2023 |
Przychody: | $26.82M |
Zysk brutto: | $17.32M (64.57 %) |
EPS: | $-6.33 |
FY | 2023 |
Przychody: | $26.82M |
Zysk brutto: | $17.32M (64.57 %) |
EPS: | $-6.33 |
FY | 2022 |
Przychody: | $14.24M |
Zysk brutto: | $12.54M (88.03 %) |
EPS: | $-1.360 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $26.55 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Agios Pharmaceuticals Inc
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej